many pituitary surgical teams because it affords superior panoramic visualization of the operative field compared with microscopic techniques. 7, 9, 14 A better understanding of the surgical and patient factors that influence postoperative sinonasal QOL and nasal morbidity may be helpful for improving patient counseling and surgical technique. In this study, we describe an exploratory post hoc analysis of a multicenter QOL study to define predictors of sinonasal morbidity and QOL after endoscopic transsphenoidal surgery.
methods study design
A post hoc analysis was conducted using data compiled during a prospective multicenter cohort study ("Rhinological Outcomes in Endonasal Pituitary Surgery" [clinical trial no. NCT01504399, clinicaltrials.gov]) of 2 commonly used transsphenoidal surgery techniques (a direct uninostril microscopic endonasal approach and a fully endoscopic endonasal approach). The study was approved by the institutional review boards at the 4 participating institutions. Informed consent was obtained from all study participants. The study adhered to the principles set forth in the US Code of Federal Regulations, Title 45, Part 46, Protection of Human Subjects, Revised January 15, 2009.
patient population
Eligible patients (consecutive English-or Spanishspeaking adults [18 years or older] with sellar pathology who had a planned primary or secondary transsphenoidal surgery) were identified in the outpatient neurosurgical clinics at 4 US pituitary centers between October 2011 and August 2013. Patients with a history of prior radiotherapy to the paranasal sinus region or skull base were excluded. A total of 301 patients were screened for eligibility; 27 patients were not eligible for the study and 39 declined to participate. From the remaining population, 123 patients received fully endoscopic surgery under the protocol. The surgeries were performed by 3 teams at 3 institutions; the fourth center did not enroll patients. The records of 10 patients were removed from the analysis because of insufficient follow-up, 6 because they were enrolled despite meeting exclusion criteria, and 7 because they underwent a second-stage surgery during the study period. The final exploratory cohort in this study comprised 100 patients who underwent a fully endoscopic surgical approach for sellar pathology. The Anterior Skull Base Nasal Inventory-12 (ASK Nasal-12) survey was completed by all 100 patients preoperatively, 99 at 2 weeks postoperatively, 95 at 3 months postoperatively, and 91 at 6 months postoperatively.
study end points
The prespecified primary end point of the study was patient-reported sinonasal QOL, which was determined by the ASK Nasal-12 at 2 weeks, 3 months, and 6 months after surgery. 12 Secondary supplementary end points included health status estimated by patient scores on the 8-item Short-Form Health Survey (SF-8) at the same time points and sinus endoscopy findings performed at various times after surgery. 17 The presence or absence and severity of mucopurulence, synechia, and crusting were recorded during nasal endoscopy.
data collection and analysis
Study data, including patient demographics, surgical approach details, and patient-reported end points, were collected and entered into a research database template by a designated research nurse at each participating site. Deidentified patient information was then forwarded to the lead site at the conclusion of the study. The SF-8 responses were scored using the scoring tool provided by Quality Metric. Data were independently analyzed by a biostatistician affiliated with the lead institution.
surgical approach and postoperative Nasal care
The surgical approach for each patient was chosen by the treating neurosurgeon. Surgical details, such as treatment of the middle turbinate, sellar repair technique, and nasal packing, were tracked. To allow study of common clinical practices, there was no prescribed postoperative nasal care protocol. Nasal rinses and endoscopic debridement were prescribed at the discretion of the treating team.
statistical analysis
Descriptive statistics and Pearson correlations were used to assess variables as potential predictors of sinonasal QOL. Variables for the final model were selected based on a series of t-tests and backward regression models that narrowed the list of potential predictors. Potential predictors included patient demographic factors, prior surgery, tumor characteristics, surgical characteristics (e.g., implant type, graft type, and fibrin glue), and complications. Potential predictors were screened in a series of univariate exploratory analyses. The final predictors selected for the model included age, sex, use of absorbable nasal packing, nasal splints, sinusitis complication, tumor functional status, participation of an otolaryngology co-surgeon, use of nasal debridement, and self-reported SF-8 scores. Other variables of interest, such as prior surgery and history of sinusitis, were not predictive in the preliminary screening models and, therefore, were not included in the final predictive model. Potential covariates for which there were insufficient numbers to evaluate, such as nasoseptal flap, were not included in the analysis. A series of linear regressions predicting postoperative ASK Nasal-12 scores at 2 weeks, 3 months, and 6 months are presented as final models. The institution where the surgery was performed was included in our models to account for potential differences in patient self-reports by site. Scatter plots were used to visualize the association between changes in ASK Nasal-12 and SF-8 scores. The Kaplan-Meier method was used to plot symptom survival. Pairwise comparisons for symptom survival curves were conducted using log-rank and Wilcoxon tests. Values presented are 2-tailed and are considered significant at p < 0.05. SPSS version 22 was used for all analyses.
results
In total, 100 patients who underwent fully endoscopic endonasal transsphenoidal surgery for pituitary lesions were included in this exploratory analysis. Patient charac-teristics are presented in Table 1 . The mean age was 51.7 ± 15.5 years and 44% of patients were male. The majority of patients presented with nonfunctioning pituitary adenomas (65%). Details regarding the surgical technique are presented in Table 2 . A majority of patients underwent fat graft placement (54%), co-surgery with an otolaryngologist (55%), and postoperative nasal debridement (76%); however, the majority of procedures did not use absorbable (80%) or nonabsorbable (92%) nasal packing. The middle turbinate was out-fractured rather than resected in all patients, and only 5% had a nasoseptal flap.
Demographics and outcomes were compared by site to justify including data from multiple sites into a single analysis. Scores for ASK Nasal-12 at 2 weeks and 3 months were significantly different by site, although the effect sizes for significant comparisons were 0.03 or less, indicating a small effect. Therefore, patients were evaluated as a single cohort. The distribution of sinonasal QOL scores worsened significantly (p < 0.001) at 2 weeks after surgery but returned to baseline by 3 months (Fig. 1 ). Sinonasal QOL scores remained unchanged at 6 months compared with 3 months. Overall, 57 of 95 (60%) and 51 of 91 (56%) patients had returned to baseline (preoperative) status at 3 and 6 months after surgery, respectively.
patient and surgical characteristics as predictors of sinonasal Qol
Linear regression models were used to predict patient self-reported sinonasal QOL scores at various time points after surgery and to determine if the predictors changed during the healing process (Table 3 ). Potential predictors evaluated in an exploratory univariate analysis included patient demographic factors, prior surgery, tumor characteristics, surgical characteristics (e.g., implant type, graft type, and fibrin glue), and complications. Significant variables were selected for the regression models.
SF-8 scores negatively correlated with ASK-12 scores at 2 weeks (p = 0.001), 3 months (p < 0.001), and 6 months (p < 0.001) and were the most influential predictor as evidenced by the standardized beta values shown in Table  3 . In other words, higher SF-8 scores (better health status) correlated with lower ASK Nasal-12 scores (better sinonasal QOL). At 2 weeks postoperatively, nasal splints emerged as a significant negative predictor (p = 0.04), while sex was significant at the trend level (p = 0.06). ASK Nasal-12 scores in male patients were on average 0.36 (95% CI -0.74 to 0.02) points lower (i.e., less severe symptoms) than scores in female patients at 2 weeks postoperatively. The use of nasal splints increased ASK-12 scores by an average of 0.57 points (95% CI 0.03-1.12).
At 3 months postoperatively, the use of absorbable na- sal packing and the development of sinusitis emerged as negative predictors of sinonasal QOL (p = 0.01 and p = 0.03, respectively). The use of absorbable nasal packing increased the average ASK Nasal-12 score by 0.47 points (95% CI 0.10-0.85). Patients experiencing sinusitis as a complication reported an average ASK Nasal-12 score of 0.54 points (95% CI 0.07-1.01) higher than those without sinusitis. Interestingly, beyond the SF-8 score, none of the surgical or patient characteristics were predictive of sinonasal QOL at 6 months, likely because most patients had healed by this time. This is a reassuring result that adds credibility to the model.
relationship of sinonasal Qol and health status
In the multivariate modeling of sinonasal QOL described above, we discovered a correlation between sinonasal QOL and general measures of health status. To explore this relationship in more detail, we created 2 change scores for each measure: a difference score from the preoperative measurement to 2 weeks postoperatively and from 2 weeks postoperatively to 6 months postoperatively. Change scores between ASK Nasal-12 and SF-8 were significantly correlated with a medium effect size at both time points, that is, r(99) = -0.32, p = 0.001 for preoperatively to 2 weeks postoperatively and r(88) = -0.38, p < 0.001 for 2 weeks to 6 months postoperatively.
Scatter plots were also used to visualize the change in the ASK Nasal-12 and SF-8 scores. A positive change score for the ASK Nasal-12 and a negative change score for the SF-8 indicate that symptoms worsened (Fig. 2) . At 2 weeks postoperatively, 85% of patients reported worsened sinonasal symptoms and 62% reported worsened health status; 53% of patients reported worsening on both measures. At 6 months postoperatively, 83% of patients reported improvement in sinonasal symptoms and 76% reported improvement in health status; 69% of patients reported improvement in both measures. These data suggest that sinonasal QOL has an important association with general measures of QOL after surgery and that sinonasal QOL may influence health status during recovery.
analysis of postoperative Nasal endoscopy Findings
A Kaplan-Meier analysis was performed to study time to resolution of nasal crusting, mucopurulence, and synechia as observed during nasal endoscopy after surgery (Fig. 3) . The mean time to absence of nasal crusting was 16.3 ± 2.1 weeks (± SEM). The mean time to absence of mucopurulence was 6.2 ± 1.1 weeks, and the mean time to absence of synechia was 4.4 ± 0.5 weeks. Crusting took significantly longer than synechia (p < 0.001) and mucopurulence (p < 0.001) to resolve.
Multivariate models were then developed to understand the surgical techniques that may be contributing to these findings. The use of absorbable nasal packing was associated at the trend level with more severe mucopurulence (p = 0.06), and the use of fibrin glue was associated at the trend level with less nasal crusting (p = 0.07). Patients with absorbable nasal packing were 10.5 times more likely to experience moderate to severe mucopurulence, and patients with fibrin glue were 1.3 times less likely to experience moderate to severe crusting, compared with patients who did not have these treatments. We examined the relationship between mucopurulence and nasal packing in more detail based on the trend described above. A Kaplan-Meier analysis was performed to predict time to mucopurulence resolution for patients with and without absorbable nasal packing (Fig. 4) . Patients with absorbable nasal packing had a significant increase in time to mucopurulence resolution (p = 0.046, Wilcoxon test). Of note is the difference in the median time to symptom resolution of 6 weeks for the patients with absorbable packing versus 2 weeks for patients without.
discussion
The goals of this study were to examine the predictors of sinonasal QOL and nasal morbidity after fully endoscopic transsphenoidal surgery to identify opportunities to improve surgical technique and improve patient counseling. We performed an exploratory post hoc analysis of a prospective cohort of 100 patients who had undergone fully endoscopic transsphenoidal surgery for pituitary lesions. The analysis of patient-reported outcome measures was supplemented with an analysis of objective nasal endoscopy findings.
This study has several primary findings. First, as expected, patients had significant worsening of sinonasal QOL 2 weeks after surgery, but generally improved to baseline by 3 months. This trend is now well documented with validated outcomes measures and demonstrates the time course of nasal cavity healing. 2, 15, 19 Symptoms such as nasal congestion and nasal discharge, while troubling to patients, were temporary. Second, we learned that certain intraoperative maneuvers that impact the nasal airway, such as use of absorbable nasal packing and nasal splints used in a minority of patients, were negatively correlated with sinonasal QOL early in the postoperative period (2 weeks to 3 months). The development of sinusitis was also a negative predictor of early sinonasal QOL; this is an expected finding and provides internal validation of our model. However, by late follow-up (6 months), none of the intraoperative maneuvers we evaluated, including fat graft, fibrin glue, nasal packing, and otolaryngology cosurgeon, were associated with sinonasal QOL. This is reassuring because it indicates the robust capacity of the sinonasal cavity to heal after transsphenoidal surgery. Nasal splints are used to prevent synechia and long-term nasal complications, but they also seem to temporarily impact nasal QOL while they are in place. Third, the strongest association we discovered was the association between sinonasal QOL and general health status. This intriguing result illustrates the impact of sinonasal QOL on a patient's overall QOL after surgery. It reinforces the notion that sinonasal morbidity is a primary source of postoperative morbidity in these patients. Strategies designed to improve sinonasal QOL, such as reducing the use of absorbable na- sal packing or those focused on reducing sinusitis, may improve the overall patient experience.
We also investigated the dynamics of synechia, mucopurulence, and nasal crusting resolution as objective correlates to the patient-reported measures. These findings were documented on postoperative nasal endoscopy performed in the otolaryngologist's office. Postoperative nasal debridement performed with an endoscope under local anesthesia is commonly used to clear the nasal airway and inspect healing after transsphenoidal surgery. Of these findings, crusting took the longest to resolve, followed by mucopurulence and synechia. When we examined the factors associated with these objective findings, we noted that absorbable nasal packing was associated with a higher incidence of postoperative mucopurulence and longer time to resolution. This provides an explanation for the impact of nasal packing on sinonasal QOL scores that we noted above. Absorbable nasal packing, such as NasoPore (Stryker), was used to achieve hemostasis, act as a buttress for the sellar repair, and prevent synechia formation. These data suggest that the use of absorbable nasal packing should be limited as it negatively, though temporarily, impacts sinonasal QOL. With respect to nasal crusting, we learned that fibrin glue was a positive prognostic factor at the trend level. This is an intriguing finding that needs to be validated in follow-up studies. We speculate that fibrin glue applied in the sphenoid sinus may prevent crusting by covering raw bony surfaces. Another interesting question that this work raises that would be a useful future direction is if the timing and frequency of debridement impact resolution of synechia, mucopurulence, and nasal crusting. Interestingly, the model did not demonstrate a relationship between sinonasal QOL and otolaryngology cosurgeon during the index procedure. We would have expected patients in whom the otolaryngology team rather than the neurosurgery team performed the nasal stage of the procedure to have reported better QOL. There are several possible explanations for this. First, in one institution, the neurosurgery team performed the nasal stage except in cases that were preoperatively felt to be more difficult or in patients who had a history of sinus concerns. Patients with persistent nasal symptoms after surgery were then subsequently referred to otolaryngology for inspection. This selection may bias the results because the more complicated cases and more symptomatic patients were cared for by the otolaryngology team. Alternatively, the results support the notion that the nasal cavity has a robust capacity to heal, such that minor differences in surgical technique are undetectable by standard QOL instruments. In any case, we feel that this question deserves further analysis. These data should not, however, be used to question the important role of our otolaryngology colleagues in the endoscopic surgery technique, particularly in symptomatic patients.
There has been recent interest in QOL after skull base surgery to supplement and illuminate objective outcome measures. 2, 3, 6, 13, 16, 19 These results are providing practitioners with valuable information for managing patient expectations and modifying surgical technique to optimize QOL. A summary of recent findings is reported in Table 4 .
In a univariate analysis of a mixed endoscopic skull base series, McCoul et al. identified revision surgery, extended endoscopic approaches, and use of allograft as negative prognostic factors. 13 As in our study, the authors did not detect a relationship between functioning pituitary tumors and sinonasal QOL. A multivariate analysis would have strengthened their analysis to identify the truly independent covariates. Our study did not examine the impact of extent of tumor resection on sinonasal QOL, although McCoul et al. reported subtotal resection as a negative prognostic factor. 13 Pant et al. 15 studied 51 patients and de Almeida et al. 6 studied 63 patients from the same institution and noted that the use of an extended approach was a negative prognostic factor. 15 These studies have methodological limitations that impact the authors' conclusions. For example, the study by Pant et al. presented limited statistical analyses. 15 Furthermore, all of the aforementioned studies are mixed series with respect to endonasal approaches, which limit their statistical power.
Several studies have demonstrated that different QOL domains and symptoms have variable responses after surgery. For example, Balaker et al. noted that postsurgical nasal discharge persisted longer than other physical nasal symptoms. 2 Zimmer et al. noted that emotional well being was markedly improved at 3 months compared with baseline, whereas nasal physiology changes had returned to baseline by 3 months. 19 Bedrosian et al. also described a dissociation of symptoms after endoscopic skull base surgery. 3 They noted that while nasal symptoms tend to worsen initially after surgery, visual symptoms tend to improve.
Our study has important strengths and limitations. The strengths of the current study are its multicenter design, larger sample size than that of previous studies, inclusion of patients with only sellar pathology undergoing standard transsphenoidal approach to allow for more specific comparisons, and multivariate data modeling. Furthermore, the patient-reported QOL end points are complemented by including general measures of health status and objective nasal endoscopy findings to give a more complete picture of the patient experience. One weakness of the study is that it is a post hoc analysis of a prospective cohort, which allows us to develop an association between variables but not necessarily determine causation. Furthermore, because of the experimental design, we are unable to study the impact of postoperative nasal care regimen (e.g., nasal rinses and Neti-pot) on sinonasal QOL.
Two additional points deserve discussion. The first is the variety of differences in surgical technique that were observed, such as the variable use of allografts, sellar implants, septal flap, and nasal packing. On the one hand, these variations represent a strength of the study because they allow us to evaluate the influence of these technical differences on QOL using a regression model. On the other hand, the variations limit the power of the study. The second point is the tumor population included in the study. We restricted enrollment to patients with sellar pathology that could be addressed through a transsphenoidal approach and excluded patients who had a planned extended approach. This helps limit the potential confounding influence of other skull base pathologies and extended approaches and is a strength compared with prior studies. Nevertheless, it does not eliminate the potential confounding effect the various tumor types might have on sinonasal QOL.
Questions of interest to pituitary surgeons that we did not examine are the impact of disease remission in patients with functioning pituitary tumors and the influence of postoperative endocrinopathies on sinonasal QOL. Our study is underpowered with respect to functioning pituitary tumors and the length of follow-up (i.e., 6 months); while this length of follow-up is sufficient for tracking sinonasal morbidity, it is not sufficient for assessing patients with functioning tumors, which can take years to evolve. For example, patients with Cushing's disease demonstrate persistent challenges in health-related QOL. 10 We did compare sinonasal QOL in patients with functioning tumors to that in patients with nonfunctioning tumors and did not note a significant difference. Furthermore, in the multivariate model, the presence of functioning tumor was not a predictor of sinonasal QOL (Table 3) . Taken together, these observations suggest that endocrine status has limited impact on sinonasal recovery in the first 6 months after endoscopic surgery.
conclusions
In this cohort of patients undergoing endoscopic pituitary surgery, sinonasal QOL and nasal morbidity reached a nadir at 2 weeks postsurgery and then improved significantly to baseline status in the majority of patients at 3 and 6 months postsurgery. Multivariate analysis showed that use of absorbable packing and nasal splints, older age, and female sex negatively correlate with sinonasal QOL. Sinonasal QOL and overall health status are also correlated in the postoperative period, suggesting the important influence of sinonasal QOL on the patient experience.
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